OpenAI
VC Fund
San Francisco, United States
OpenAI is an AI research and deployment company that conducts research and develops machine learning technologies. OpenAI works on projects that involve autonomous learning and task performance. It serves industries such as technology, healthcare, and education.
- Total investments:
- 43
- Last investment:
- Lead investor:
- 35%
- Fund size:
- $100M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries OpenAI invests in
Stages OpenAI invests in
Countries OpenAI invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Hessam Bagherinezhad
|
|||
Scott Gray
|
|||
Venkat Venkataramani
|
Investment Focus
Industry
- Artificial Intelligence 23 (53%)
- Software 9 (21%)
- Information Technology 7 (16%)
- Machine Learning 5 (12%)
- Hardware 3 (7%)
Stage
- Seed 10 (23%)
- Grant 8 (19%)
- Series A 8 (19%)
- Series C 4 (9%)
- Corporate Round 4 (9%)
Country
- United States 27 (63%)
- Canada 2 (5%)
- France 1 (2%)
- United Kingdom 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Hemal Shah
Product
|
Product | Total investments: 1 | Find email | |
|
Hessam Bagherinezhad
Member of Technical Staff
|
Member of Technical Staff | Total investments: 0 | Find email | |
Sarah Friar
CFO
|
CFO | Total investments: 8 | Find email | |
|
Scott Gray
Member of Technical Staff
|
Member of Technical Staff | Total investments: 0 | Find email | |
|
Venkat Venkataramani
VP of Platform Infrastructure
|
VP of Platform Infrastructure | Total investments: 2 | Find email | |
| See all 18 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Chai Discovery
|
Chai Discovery creates Chai-1, a multi-modal foundation model designed for predicting molecular structures relevant to drug discovery. The model facilitates the unified prediction of proteins, small molecules, and nucleic acids, and is available for free for commercial applications. By enabling accurate predictions without the need for multiplesequence alignments, Chai-1 advances the capabilities of molecular modeling in the life sciences. | $400M / Series C / Jul 14, 2026 | |
Poetic
|
Poetic is an AI-focused technology company that develops a platform designed to automate complex, multi-step business workflows that typically require human judgment and coordination. It builds tools that allow organizations to use AI systems more reliably in areas such as compliance, underwriting, and other structured enterprise processes. Thecompany’s approach centers on combining software-like reliability with AI-driven adaptability to handle unstructured or dynamic tasks. It provides infrastructure that helps businesses integrate AI into existing operations without fully replacing their core systems. The platform is used to support industries where accuracy, traceability, and process control are important. | $50M / Series A / Jun 10, 2026 | |
Poetic
|
Poetic is an AI-focused technology company that develops a platform designed to automate complex, multi-step business workflows that typically require human judgment and coordination. It builds tools that allow organizations to use AI systems more reliably in areas such as compliance, underwriting, and other structured enterprise processes. Thecompany’s approach centers on combining software-like reliability with AI-driven adaptability to handle unstructured or dynamic tasks. It provides infrastructure that helps businesses integrate AI into existing operations without fully replacing their core systems. The platform is used to support industries where accuracy, traceability, and process control are important. | $50M / Series A / Jun 10, 2026 | |
Eleplan
|
Eleplan comprehensive platform designed to streamline care planning, focusing on creating, managing, and sharing detailed, structured care. | $100K / Grant / May 14, 2026 | |
Biossil
|
Biossil is an applied AI drug discovery platform to create specialized treatments for distinct patients. | $70M / Venture - Series Unknown / Apr 23, 2026 | |
Isara Laboratories
|
Isara Laboratories operates as an artificial intelligence startup. | $94M / Series A / Mar 25, 2026 | |
Linux Foundation
|
The Linux Foundation is a non-profit organization that promotes, protects, and standardizes open source software by hosting important workgroups, events, and online resources. Founded in 2000, The Linux Foundation provides unparalleled support for open source communities through financial and intellectual resources, infrastructure, services,events, and training. Working together, The Linux Foundation and its projects form the most ambitious and successful investment in the creation of shared technology. For years the Linux Foundation has provided a neutral home and unmatched support for cutting-edge projects — fostering burgeoning communities that breed collaboration, power innovation, and attract the best engineering talent in the world. | $12.5M / Grant / Mar 17, 2026 | |
Alpha-Omega
|
Alpha-Omega protects society by funding and catalyzing sustainable security across open source software. | Grant / Mar 17, 2026 | |
Open Source Security Foundation
|
The non-profit software foundation working to solve security problems in the open source supply chain. | Grant / Mar 17, 2026 | |
Merge Labs
|
Merge Labs provides a unified application programming interface that enables software companies to connect with multiple third-party platforms through a single integration. The company’s products support integrations across categories such as accounting, customer relationship management, human resources, ticketing, and payments. Its platformhandles data normalization, authentication, sync scheduling, and error handling to reduce the effort required to build and maintain integrations. Merge Labs also offers tools for monitoring data syncs, managing permissions, and controlling access across connected systems. The service is designed for engineering and product teams that need to scale integrations while maintaining consistent data flows between applications. | $252M / Seed / Jan 15, 2026 | |
| See all 43 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does OpenAI invest in?
OpenAI invests primarily in Artificial Intelligence, Software and Information Technology startups, most often at Seed and Grant stage. Most of the 43 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact OpenAI?
Public channels for OpenAI include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at OpenAI?
The team at OpenAI includes Hemal Shah (Product), Hessam Bagherinezhad (Member of Technical Staff) and Sarah Friar (CFO), among 18 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
